Skip to content
Screener

Biogen BIIB Operating margin

Discontinued — last reported Q1 '22

Operating margin at other companies

Rogers Corporation logo
Rogers CorporationROG
8.1%-6.7pp
TG Therapeutics logo
TG TherapeuticsTGTX
21.3%+5.9pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
7.4%-16.2pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
17.6%+9.6pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-102.8%-47.8pp
Regenxbio logo
RegenxbioRGNX
-292.3%-613pp

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M—
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$29.99B+54.7%
Enterprise value$36.26B+56.2%
P/E33.9×+21.3×
P/S3×+1.1×

Profitability

See full
Gross margin74%-1.4pp
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Calculated from Biogen’s reported figures.

operating income/total revenue=22.9%

Based on trailing twelve months.

The source filing: Biogen’s 10-Q, filed May 3, 2022. Open the filing →

Filed
May 3, 2022
Fiscal quarter
Q1 FY2022
Calendar quarter
Q1 2022
Accession
0000875045-22-000016

FAQ

What is Biogen's operating margin?
Biogen (BIIB) reported operating margin of 22.9% in Q1 2022.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Biogen's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude